Abstract: This invention relates to a polymer composition comprising a water-soluble anionic P2 polymer obtained by radical polymerization of at least one anionic monomer, in the presence of a water-soluble homopolymer P1 with a weight-average molecular weight of between 5,000 and 100,000 daltons said water-soluble anionic P2 polymer having a weight-average molecular weight of greater than 100,000 dalton and less than or equal to 40 million daltons, said water-soluble P1 homopolymer having been prepared from 2-acrylamido-2-methylpropanesulphonic acid in salified form and in the presence of 200 to 20,000 ppm by weight of 2-methyl-2-propenylsulphonic acid in salified form.

Abstract: The present invention concerns a kit and methods for the detection of absence or presence of a ?-lactamase, for example a penicillinase, in a sample comprising or derived from a body fluid taken from a patient suffering from an infection. In some embodiments, the goal of the invention is to rapidly identify infections which can be treated effectively with a penicillin compound. The invention contributes to slowing down the occurrence of resistances to last generation antibiotics. This is achieved by using penicillin compounds for treating infections whenever this can be done efficiently. In brief, the present invention provides a tool for maximizing the use and efficiency of penicillin antibiotics. In other embodiments, the test kit of the invention can be used to detect cephalosporinases (including ESBLs) or carbapenemases.

Abstract: The present invention concerns a kit and methods for the detection of absence or presence of a ?-lactamase, for example a penicillinase, in a sample comprising or derived from a body fluid taken from a patient suffering from an infection. In some embodiments, the goal of the invention is to rapidly identify infections which can be treated effectively with a penicillin compound. The invention contributes to slowing down the occurrence of resistances to last generation antibiotics. This is achieved by using penicillin compounds for treating infections whenever this can be done efficiently. In brief, the present invention provides a tool for maximizing the use and efficiency of penicillin antibiotics. In other embodiments, the test kit of the invention can be used to detect cephalosporinases (including ESBLs) or carbapenemases.